Voting Opens to Select the Winner of the 2011 IN Cell Analyzer Image Competition

GE HealthcareGE Healthcare Life Sciences announced that voting for the 2011 IN Cell Analyzer Image Competition is now open. Both scientists and the wider public are invited to choose their favourite from 30 shortlisted images submitted by researchers worldwide.

When making their selection, voters can consider the beauty of the image, their interest in the science behind it, or a combination of the two. The winning entrants from each region (Americas, Europe and Asia/Rest of World) will be invited to New York to see their images projected on NBC's high definition screen in Times Square.

Carmen Laethem, Aerie Pharmaceuticals, a previous winner and a judge on the 2011 shortlisting panel, said, "The images of cells that scientists produce every day on the IN Cell Analyzer can be captivatingly beautiful, some reminiscent of scenes from nature or even evoking the visual style of artists such as Jackson Pollock or Miró. Behind that beauty lies valuable data which enables researchers to, for example, better understand the mechanisms behind disease at the cellular level or conduct early screens for potential new therapies."

Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences, said, "Once again, we have an exciting range of images from around the world. We're proud of how they showcase the capabilities of cellular imaging with our IN Cell Analyzer systems but also believe scientists should share the images with friends and family to inspire them with the beauty of cells and provide an accessible introduction to their own research."

To view the shortlisted images and vote for your favourite, please visit:
http://www.gelifesciences.com/incellcompetition

Related news articles:

About the 2011 IN Cell Analyzer Image Competition
The IN Cell Image Competition, supported by BioTechniques, celebrates the outstanding research enabled by the superior image quality that IN Cell Analyzer systems deliver. Voting starts on 7 November and continues online until mid-December. Attendees at two conferences (ASCB, December 3-7, USA and MBSJ, December 13-16, Japan) will also be invited to vote for their favourite. The votes will be combined to select 3 winners, one from each region (Americas, Europe, Asia/Rest of World). Details of the judging panel can be found here and full terms and conditions can be found here.

About GE Healthcare's IN Cell Analyzer system
IN Cell Analyzer automated high content cell imagers, IN Cell Investigator image analysis software and IN Cell Miner data management software combine to provide a system that represents a total solution for high content sub cellular analysis in research and drug discovery. High-performance hardware, powerful software, and expert instrument and applications support are harmonized to transform the cellular workflow.

IN Cell Analyzer 2000 is a highly flexible, lamp-based high-content imaging instrument impressively enabling for a wide range of assays and techniques. The latest addition to the IN Cell Analyzer family, IN Cell Analyzer 6000 is a high-end, laser based confocal imaging platform for the most demanding high-content assays and screens. Featuring a novel and proprietary optical system that incorporates an iris-like variable aperture design and next-generation sCMOS technology, IN Cell Analyzer 6000 balances speed and image quality for challenging and variable assays.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...